CLXConsumer Defensive · Household & Personal ProductsThe 18 Wall Street analysts covering The Clorox Co. hold a median 12-month price target of $98 — +21.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 29 of 100 as at 2 Oct 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores The Clorox Co. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (85): The business earns solid, repeatable profits on what it owns.
Growth (21): Sales and profits are flat, shrinking, or growing more slowly than they were.
Size (16): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on CLX, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +21.9% from it.
Of the 20 most recent actions, 6 moved their price target up and 5 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 11 Sept 2026 | Citigroup | Maintains | Neutral | $100 → $97 |
| 11 Sept 2026 | Wells Fargo | Maintains | Equal-Weight | $102 → $90 |
| 4 Aug 2026 | Citigroup | Maintains | Neutral | $97 → $100 |
| 4 Aug 2026 | Citigroup | Maintains | Neutral | — |
| 4 Aug 2026 | Evercore ISI Group | Maintains | Underperform | $98 → $99 |
| 4 Aug 2026 | Evercore ISI Group | Maintains | Underperform | — |
| 4 Aug 2026 | JP Morgan | Maintains | Underweight | $92 → $95 |
| 4 Aug 2026 | JP Morgan | Maintains | Underweight | — |
| 4 Aug 2026 | UBS | Maintains | Neutral | $100 → $105 |
| 4 Aug 2026 | UBS | Maintains | Neutral | — |
| 4 Aug 2026 | Wells Fargo | Maintains | Equal-Weight | $95 → $102 |
| 4 Aug 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 28 July 2026 | Jefferies | Downgrade | Hold | $125 → $98 |
| 28 July 2026 | Jefferies | Downgrade | Hold | — |
| 23 July 2026 | Evercore ISI Group | Maintains | Underperform | $110 → $98 |
| 23 July 2026 | Evercore ISI Group | Maintains | Underperform | — |
| 21 July 2026 | Barclays | Maintains | Underweight | $85 → $86 |
| 21 July 2026 | Barclays | Maintains | Underweight | — |
| 20 July 2026 | BNP Paribas | Maintains | Neutral | — |
| 20 July 2026 | BNP Paribas | Maintains | Neutral | $97 → $95 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CLX appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 2 Oct 2026, The Clorox Co. returned −31.2% against +16.2% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 42% of US stocks
Cheaper than 60% of US stocks
Cheaper than 1% of US stocks
Cheaper than 26% of US stocks
Higher than 24% of US stocks
Higher than 11% of US stocks
Higher than 51% of US stocks
Higher than 69% of US stocks
Higher than 67% of US stocks
Higher than 98% of US stocks
Higher than 89% of US stocks
Higher than 85% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
The Clorox Co. has a market value of $9.7B and an enterprise value of $15.3B.
Revenue in the twelve months to 30 June 2026: $6.7B. The latest quarter shrank 2.0% year on year.
Net income over the same four quarters: $601.0M, a 8.9% net margin.
Free cash flow in the twelve months to 30 June 2026: $405.0M, after $207.0M of capital spending.
The Clorox Co. spent $256.0M on share buybacks and $602.0M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 16.7×; forward P/E: 12.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 6.22%, paying out 103% of earnings.
The Clorox Co. employs 9,200 people — $730K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own The Clorox Co. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Clorox experienced strong demand during the pandemic, but since the economic reopening it has faced a series of ongoing difficulties.
Why it matters — CLX watchers would care because the company is navigating multiple years of challenging circumstances following a pandemic-era boom.
Zacks reports that Clorox's growth outlook is supported by its innovation efforts, the GOJO acquisition, and its digital transformation, which are strengthening the company's health and hygiene portfolio while supporting long-term growth.
Why it matters — A Clorox watcher would care because the company's innovation, GOJO acquisition, and digital initiatives are positioned to reinforce its health and hygiene portfolio and support its long-term growth trajectory.
Zacks Investment Research reports that recent movements in the options market for Clorox (CLX) suggest investors should pay close attention to the stock, with the article examining whether the options activity points to a possible spike in the share price.
Why it matters — Clorox watchers would care because unusual options-market activity can signal shifts in investor expectations for the stock's near-term price direction.
Clorox trades at a depressed 14x forward P/E with a 6% dividend yield, but analysts note ongoing challenges from inflation, weak volumes, and integration risks from the GOJO acquisition. A hold rating is maintained, with a full turnaround considered at least 12–24 months away and upside dependent on cost synergies and margin recovery.
Why it matters — A Clorox watcher would care because the article highlights that despite an attractive valuation and yield, near-term organic growth and margin recovery remain constrained, with a meaningful turnaround not anticipated for another one to two years.
The Clorox Company announced the official launch of Clorox Purell ProCare, a new B2B-focused business created through the combination of CloroxPro and GOJO, Makers of Purell. The venture aims to give professional and healthcare customers access to trusted health and hygiene solutions.
Why it matters — A CLX watcher would care because this new B2B venture expands the company's reach in the professional and healthcare hygiene market by combining two well-known brands.
The 18 Wall Street analysts covering The Clorox Co. have a median 12-month price target of $98, with estimates ranging from $77 to $154. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 18 analysts covering The Clorox Co., 1 rate it a Buy, 13 a Hold and 4 a Sell. Ticker Nerd's systematic factor model ranks The Clorox Co. 29 out of 100 across roughly 4,600 US stocks as at 2 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 2 Oct 2026, The Clorox Co. ranks 29 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (85 of 100).
No one can know that. What the data says: the median 12-month target from 18 analysts implies +21.9% from the last close, and Ticker Nerd's factor model ranks The Clorox Co. 29 out of 100 as at 2 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering The Clorox Co. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CLX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $77 to $154 over the next 12 months.
The Clorox Co. returned -31.2% over the 12 months to 2 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
The Clorox Company is a consumer products company that develops, manufactures, and markets a broad range of household and professional brands worldwide. Its portfolio spans cleaning and disinfecting products, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration, grilling products, and natural personal care items.
The most recent item we track (The Motley Fool, 3 Oct 2026): "Clorox is Dealing With Several Years of Challenging Circumstances". Clorox experienced strong demand during the pandemic, but since the economic reopening it has faced a series of ongoing difficulties.
The Clorox Company is a consumer products company that develops, manufactures, and markets a broad range of household and professional brands worldwide. Its portfolio spans cleaning and disinfecting products, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration, grilling products, and natural personal care items. The company serves both retail and professional customers through well-known brands including Clorox, Pine-Sol, Glad, Fresh Step, Kingsford, Brita, Burt’s Bees, Hidden Valley, and CloroxPro. The Clorox Company operates across multiple business segments, including Health and Wellness, Household, Lifestyle, and International, giving it a diversified presence in everyday consumer needs and institutional cleaning markets. Headquartered in Oakland, California, The Clorox Company focuses on essential products that support home care, hygiene, food preparation, and sanitation in markets around the world.
CEO Ms. Linda J. Rendle · 9,200 employees · United States · https://www.thecloroxcompany.com
